Peak Sales Potential of Merck's (MRK) Keytruda is Underappreciated - Analyst

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/16/2026

1. SPY
2. JBHT
3. ASML
4. ATAI
5. NVDA
6. JNJ
7. TSM
8. UNH
9. BNY
10. PNC

Go back to Peak Sales Potential of Merck's (MRK) Keytruda is Underappreciated - Analyst
Merck & Co. (NYSE: MRK) Delayed: 127.63 +4.02 (3.25%)
Previous Close $123.61    52 Week High $65.46 
Open $124.33    52 Week Low $47.97 
Day High $128.93    P/E 86.82 
Day Low $124.00    EPS $1.47 
Volume 13,063,776